Sihuan Pharmaceutical Holdings Group Ltd.

Sihuan Pharmaceutical Holdings Group Ltd.

SHPHF
Sihuan Pharmaceutical Holdings Group Ltd.US flagOther OTC
0.19
USD
- -
- -
1.69BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
0.25
0.3
0.31
0.31
0.29
0.31
0.3
0.26
0.32
0.23
0.2
0.21
0.29
Basic EPS, GAAP
0.12
0.16
0.2
0.17
0.15
0.17
-0.29
0.05
0.04
-0.21
-0.01
-0.02
0.02
Free Cash Flow per Basic Share
0.04
0.1
0.09
0.16
0.15
0.15
0.08
-0.04
-0.01
-0.06
-0.01
0.01
-0.02
Dividend per Share
0.05
0.02
0.03
0.06
0.12
0.03
0.02
0.15
0.01
0.14
0.03
0.02
0.01
Book Value per Share
0.21
0.34
0.52
0.63
0.72
0.87
0.56
0.46
0.49
0.15
0.11
0.06
0.07
Tangible Book Value per Share
0.49
0.64
0.81
0.8
0.75
0.83
1
1
0.9
0.54
0.47
0.44
0.65
Basic Weighted Avg Shares
10,350
10,363
10,364
10,141
9,483
9,471
9,468
9,466
9,431
9,330
9,297
9,266
9,121
Sales/Revenue/Turnover
2,586
3,084
3,167
3,186
2,746
2,917
2,878
2,464
3,038
2,181
1,861
1,901
2,618
Operating Margin (%)
57.04
61.55
64.84
58
51.61
57.26
46.93
18.22
21.32
-25.41
-10.29
-24.3
14.33
Depreciation Expense
196
209
263
291
297
307
355
278
309
370
226
258
225
Net Income, GAAP
1,285
1,671
2,062
1,708
1,449
1,620
-2,753
473
417
-1,915
-54
-217
180
Effective Tax Rate (%)
19.39
18.74
28.04
21.96
14.47
16.54
- -
28.6
51.03
- -
- -
- -
55.56
Profit Margin (%)
49.68
54.19
65.12
53.62
52.77
55.53
-95.66
19.21
13.71
-87.79
-2.9
-11.4
6.86
Working Capital
3,320
3,933
4,513
4,156
2,871
3,528
4,044
3,961
5,240
4,017
2,097
2,407
2,963
LT Debt
6
4
8
- -
- -
95
15
362
876
929
957
759
735
Total Equity
7,937
9,406
11,192
10,971
11,336
12,774
9,942
9,949
9,150
5,640
5,137
4,949
6,900
Return on Invested Capital (%)
14.42
17.21
14.04
12.75
10.64
11.36
- -
3.1
3.02
- -
- -
- -
2.41
Return on Capital (%)
53.3
53.62
45.41
28.91
20.54
19.65
- -
7.61
10.55
- -
- -
- -
10.84
Return on Common Equity (%)
71.32
58.4
46.28
29.03
21.92
21.52
-40.53
9.75
9.25
-63.76
-4.49
-27.1
28.65

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-2.76%
-3.91%
39.42%
Free Cash Flow
-39.04%
-50.82%
-342.92%
Net Income, GAAP
-95.85%
-110.16%
-182.94%
Sales/Revenue/Turnover
-0.24%
4.06%
37.71%
Total Cash Common Dividend
144.81%
142.47%
-48.67%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1,861
2024
- -
- -
- -
- -
1,901
2025
- -
- -
- -
- -
2,618

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.01
2024
- -
- -
- -
- -
-0.02
2025
- -
- -
- -
- -
0.02

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.03
2024
- -
- -
- -
- -
0.02
2025
- -
- -
- -
- -
0.01

Company Description

APIChat
CEO
Weicheng Guo
Full Time Employees
2,667
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
Convention Plaza Wan Chai Hong Kong
IPO Date
Jan 13, 2012
Business
The search did not yield specific recent major changes or detailed product information for Sihuan Pharmaceutical Holdings Group Ltd. I will now focus on directly searching for information on Sihuan Pharmaceutical Holdings Group Ltd. (Ticker: SHPHF) including its latest corporate updates, product details, services, geographic operations, and recent strategic developments.